TITLE

Xenical's marketing appeal: Obesity is not in the mind, it is in the gut

PUB. DATE
June 1999
SOURCE
Medical Marketing & Media;Jun99, Vol. 34 Issue 6, p18
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Focuses on the marketing plans for the weight-loss substance called Orlistat from Hoffmann-La Roche Inc. Action of the drug on blocking dietary fat.
ACCESSION #
2076147

 

Related Articles

  • Viagra for the Thighs? Lemonick, Michael D.; Park, Alice // Time International (South Pacific Edition);05/10/1999, Issue 19, p58 

    Announces the release of the drug orlistat for weight loss in the United States. Drug to be manufactured by Hoffman-LaRoche as Xenical; Possible side effects; How the drug works; Importance of changing one's eating habits and exercising; Critics of putting the drug on the market.

  • Viagra for the Thighs? Lemonick, Michael D.; Park, Alice // Time;5/10/1999, Vol. 153 Issue 18, p72 

    Announces the release of the drug orlistat for weight loss in the United States. Drug to be manufactured by Hoffman-LaRoche as Xenical; Possible side effects; How the drug works; Importance of changing one's eating habits and exercising; Critics of putting the drug on the market.

  • New fat blocker?  // Joe Weider's Muscle & Fitness;Apr94, Vol. 55 Issue 4, p25 

    Reports on the development of the drug orlistat by Hoffman-La Roche for keeping some consumed fat from being broken down and used by the body. Recommended for the seriously overweight; Testing for the effectivity of orlistat.

  • Finally, the Free Lunch? Springen, Karen // Newsweek;2/1/1999, Vol. 133 Issue 5, p57 

    Reports on orlistat, a drug that blocks the absorption of dietary fat developed by Hoffman-La Roche and under consideration for approval by the United States Food and Drug Administration (FDA) as of January 1999. Details of the study of the obesity drug, and comments from study author John...

  • Obesity drugs trim ads. Goetzl, David // Advertising Age;8/13/2001, Vol. 72 Issue 33, p10 

    The article reports on the decision of obesity drug manufacturers Hoffmann-La Roche and Abbott Pharmaceuticals to discontinue direct-to-consumer (DTC) advertising for their products. Hoffmann-La Roche's new campaign, launched in February 2001, which was designed in part to divert attention from...

  • Pharmacy care Kit available from Roche.  // Drug Topics;10/10/94, Vol. 138 Issue 19, p8 

    Reports on the availability of a pharmacy counseling service from Roche Laboratories for patients on Roferon-A therapy.

  • Toradol labeling changed.  // Drug Topics;3/6/95, Vol. 139 Issue 5, p8 

    Reports on Roche Laboratories decision to change the labeling on its Toradol prescription pain reliever due to reports on side effects from improper use. Usage of the drug for pain management in postsurgical patients.

  • Program prevents pregnancies during tx.  // Dermatology Times;Sep95, Vol. 16 Issue 9, p3 

    Reports on the pregnancy prevention program conducted by Hoffman-La Roche Inc. during isotretinoin treatment for its patients.

  • La Roche lottery.  // Northern New Jersey Business;6/28/95, Vol. 3 Issue 13, p3 

    Reports on the US Food and Drug Administration's approval of the drug called Invirase, manufactured by Hoffman-La Roche.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics